MEDI-551

inebilizumab · MedImmune LLC

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for MEDI-551, covering 2014-11-13 to 2020-05-13. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study Using MEDI-551 in Adult Participants With Relapsed or Refractory Advanced B-Cell Malignancies [Phase 1, Phase 2]

See pricing